147 related articles for article (PubMed ID: 33128858)
21. Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series.
Gandaglia G; Fossati N; Karnes RJ; Boorjian SA; Colicchia M; Bossi A; Seisen T; Cozzarini C; Di Muzio N; Noris Chiorda B; Zaffuto E; Wiegel T; Shariat SF; Goldner G; Joniau S; Battaglia A; Haustermans K; De Meerleer G; Fonteyne V; Ost P; Van Poppel H; Montorsi F; Briganti A
Eur Urol; 2018 Apr; 73(4):512-518. PubMed ID: 29229176
[TBL] [Abstract][Full Text] [Related]
22. Effect of pelvic lymph node irradiation in salvage therapy for patients with prostate cancer with a biochemical relapse following radical prostatectomy.
Kim BS; Lashkari A; Vongtama R; Lee SP; Parker RG
Clin Prostate Cancer; 2004 Sep; 3(2):93-7. PubMed ID: 15479492
[TBL] [Abstract][Full Text] [Related]
23. Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey.
Ariane MM; Ploussard G; Rebillard X; Malavaud B; Rischmann P; Hennequin C; Mongiat-Artus P
World J Urol; 2015 Nov; 33(11):1741-7. PubMed ID: 25822706
[TBL] [Abstract][Full Text] [Related]
24. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.
Stephenson AJ; Shariat SF; Zelefsky MJ; Kattan MW; Butler EB; Teh BS; Klein EA; Kupelian PA; Roehrborn CG; Pistenmaa DA; Pacholke HD; Liauw SL; Katz MS; Leibel SA; Scardino PT; Slawin KM
JAMA; 2004 Mar; 291(11):1325-32. PubMed ID: 15026399
[TBL] [Abstract][Full Text] [Related]
25. Identifying appropriate patients for early salvage radiotherapy after prostatectomy.
Karlin JD; Koontz BF; Freedland SJ; Moul JW; Grob BM; Wan W; Hagan MP; Anscher MS; Moghanaki D
J Urol; 2013 Oct; 190(4):1410-5. PubMed ID: 23648223
[TBL] [Abstract][Full Text] [Related]
26. Knowledge, attitudes and beliefs towards management of men with locally advanced prostate cancer following radical prostatectomy: an Australian survey of urologists.
Brown B; Young J; Kneebone AB; Brooks AJ; Dominello A; Haines M
BJU Int; 2016 Apr; 117 Suppl 4():35-44. PubMed ID: 25585989
[TBL] [Abstract][Full Text] [Related]
27. Does Specialty Bias Trump Evidence in the Management of High-risk Prostate Cancer?
Kishan AU; Duchesne G; Wang PC; Rwigema JM; Saigal C; Rettig M; Steinberg ML; King CR
Am J Clin Oncol; 2018 Jun; 41(6):549-557. PubMed ID: 27560157
[TBL] [Abstract][Full Text] [Related]
28. Risk of biochemical recurrence and timing of radiotherapy in pT3a N0 prostate cancer with positive surgical margin : A single center experience.
Hegemann NS; Morcinek S; Buchner A; Karl A; Stief C; Knüchel R; Corradini S; Li M; Belka C; Ganswindt U
Strahlenther Onkol; 2016 Jul; 192(7):440-8. PubMed ID: 27272660
[TBL] [Abstract][Full Text] [Related]
29. Population-based analysis of salvage radical prostatectomy with examination of factors associated with adverse perioperative outcomes.
Pearce SM; Richards KA; Patel SG; Pariser JJ; Eggener SE
Urol Oncol; 2015 Apr; 33(4):163.e1-6. PubMed ID: 25708953
[TBL] [Abstract][Full Text] [Related]
30. National trends in the recommendation of radiotherapy after prostatectomy for prostate cancer before and after the reporting of a survival benefit in March 2009.
Mahal BA; Hoffman KE; Efstathiou JA; Nguyen PL
Clin Genitourin Cancer; 2015 Jun; 13(3):e167-72. PubMed ID: 25554010
[TBL] [Abstract][Full Text] [Related]
31. Urologists' referral and radiation oncologists' treatment patterns regarding high-risk prostate cancer patients receiving radiotherapy within 6 months after radical prostatectomy: A prospective cohort analysis.
Egger S; Smith DP; Brown BB; Kneebone AB; Dominello A; Brooks AJ; Young J; Xhilaga M; Haines M; O'Connell DL
J Med Imaging Radiat Oncol; 2020 Feb; 64(1):134-143. PubMed ID: 31793211
[TBL] [Abstract][Full Text] [Related]
32. Differential Risk of Castration Resistance After Initial Radical Prostatectomy or Radiotherapy for Prostate Cancer.
Obata H; Shiota M; Akitake N; Takeuchi A; Kashiwagi E; Dejima T; Kiyoshima K; Inokuchi J; Tatsugami K; Eto M
Anticancer Res; 2017 Oct; 37(10):5631-5637. PubMed ID: 28982880
[TBL] [Abstract][Full Text] [Related]
33. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
[TBL] [Abstract][Full Text] [Related]
34. Trends in the Use of Stereotactic Body Radiotherapy for Treatment of Prostate Cancer in the United States.
Mahase SS; D'Angelo D; Kang J; Hu JC; Barbieri CE; Nagar H
JAMA Netw Open; 2020 Feb; 3(2):e1920471. PubMed ID: 32022878
[TBL] [Abstract][Full Text] [Related]
35. Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis.
Briganti A; Wiegel T; Joniau S; Cozzarini C; Bianchi M; Sun M; Tombal B; Haustermans K; Budiharto T; Hinkelbein W; Di Muzio N; Karakiewicz PI; Montorsi F; Van Poppel H
Eur Urol; 2012 Sep; 62(3):472-87. PubMed ID: 22633803
[TBL] [Abstract][Full Text] [Related]
36. First Postprostatectomy Ultrasensitive Prostate-specific Antigen Predicts Survival in Patients with High-risk Prostate Cancer Pathology.
Kang JJ; Reiter RE; Steinberg ML; King CR
Eur Urol Oncol; 2018 Oct; 1(5):378-385. PubMed ID: 31158076
[TBL] [Abstract][Full Text] [Related]
37. Radiation therapy after radical prostatectomy: a review of the issues and options.
Valicenti RK; Gomella LG; Perez CA
Semin Radiat Oncol; 2003 Apr; 13(2):130-40. PubMed ID: 12728442
[TBL] [Abstract][Full Text] [Related]
38. Assessing the Role and Optimal Duration of Hormonal Treatment in Association with Salvage Radiation Therapy After Radical Prostatectomy: Results from a Multi-Institutional Study.
Fossati N; Robesti D; Karnes RJ; Soligo M; Boorjian SA; Bossi A; Coraggio G; Di Muzio N; Cozzarini C; Noris Chiorda B; Gandaglia G; Scarcella S; Bartkowiak D; Böhmer D; Shariat S; Goldner G; Battaglia A; Joniau S; Haustermans K; De Meerleer G; Fonteyne V; Ost P; Van Poppel H; Montorsi F; Wiegel T; Briganti A
Eur Urol; 2019 Oct; 76(4):443-449. PubMed ID: 30799187
[TBL] [Abstract][Full Text] [Related]
39. Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective, cohort study.
Mohamad O; Tabuchi T; Nitta Y; Nomoto A; Sato A; Kasuya G; Makishima H; Choy H; Yamada S; Morishima T; Tsuji H; Miyashiro I; Kamada T
Lancet Oncol; 2019 May; 20(5):674-685. PubMed ID: 30885458
[TBL] [Abstract][Full Text] [Related]
40. Utilization of Salvage Radiation Therapy for Biochemical Recurrence After Radical Prostatectomy.
Hawken SR; Spratt DE; Qi J; Linsell SM; Cher ML; Ghani KR; Miller DC; Montie JE; Morgan TM;
Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1030-1034. PubMed ID: 30682490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
